Literature DB >> 2443495

Anchoring fibrils contain the carboxyl-terminal globular domain of type VII procollagen, but lack the amino-terminal globular domain.

G P Lunstrum1, H J Kuo, L M Rosenbaum, D R Keene, R W Glanville, L Y Sakai, R E Burgeson.   

Abstract

Type VII procollagen has been characterized as a product of epithelial cell lines. As secreted, it contains a large triple-helical domain terminated by a multi-globular-domained carboxyl terminus (NC-1), and a smaller amino-terminal globule (NC-2). The triple helix and the NC-1 domain have previously been identified in anchoring fibril-containing tissues by biochemical and immunochemical means, leading to the conclusion that type VII collagen is a major component of anchoring fibrils. In order to better characterize the tissue form of type VII collagen, we have produced a panel of monoclonal antibodies which recognize the NC-1 domain. Peptide mapping of these epitopes indicate that they are independent and span approximately 125,000 kDa of the total 150,000 kDa of each alpha chain contained in NC-1. All these antibodies elicit immunofluorescent staining of the basement membrane zone in tissues. Type VII collagen has been extracted from tissues. As previously reported, it is smaller than type VII procollagen, (Woodley, D. T., Burgeson, R. E., Lunstrum, G. P., Bruckner-Tuderman, L., and Briggaman, R. A., submitted for publication), and we now find that it predominantly occurs as a dimer. Following clostridial collagenase digestion, intact NC-1 has been recognized, indicating that the difference in apparent Mr between the tissue form of the molecule and type VII procollagen results from modification of the amino terminus. The size of the amino-terminal globule has been determined to be between approximately 96 and 102 kDa. Rotary shadowing analyses of extracted molecules indicate that dimeric molecules contain the NC-1 domain, but are missing intact NC-2. We propose that the tissue form monomer, Mr = 960,000, be referred to as "type VII collagen." These studies strongly suggest that anchoring fibrils contain dimeric molecules with intact NC-1 domains. The data also support the previous suggestion that the NC-2 domain is involved in the formation of disulfide bond-stabilized type VII collagen dimers, and is subsequently removed by physiological proteolytic processing.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2443495

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

Review 1.  The bone morphogenetic protein 1/Tolloid-like metalloproteinases.

Authors:  Delana R Hopkins; Sunduz Keles; Daniel S Greenspan
Journal:  Matrix Biol       Date:  2007-05-18       Impact factor: 11.583

2.  Human type VII collagen: genetic linkage of the gene (COL7A1) on chromosome 3 to dominant dystrophic epidermolysis bullosa.

Authors:  M Ryynänen; R G Knowlton; M G Parente; L C Chung; M L Chu; J Uitto
Journal:  Am J Hum Genet       Date:  1991-10       Impact factor: 11.025

3.  Laminins, tenascin and type VII collagen in colorectal mucosa.

Authors:  J Lohi; I Leivo; T Tani; T Kiviluoto; E Kivilaakso; R E Burgeson; I Virtanen
Journal:  Histochem J       Date:  1996-06

4.  Characterization of molecular mechanisms underlying mutations in dystrophic epidermolysis bullosa using site-directed mutagenesis.

Authors:  David T Woodley; Yingping Hou; Sabrina Martin; Wei Li; Mei Chen
Journal:  J Biol Chem       Date:  2008-04-30       Impact factor: 5.157

5.  BMP1-like proteinases are essential to the structure and wound healing of skin.

Authors:  Alison M Muir; Dawiyat Massoudi; Ngon Nguyen; Douglas R Keene; Se-Jin Lee; David E Birk; Jeffrey M Davidson; M Peter Marinkovich; Daniel S Greenspan
Journal:  Matrix Biol       Date:  2016-06-27       Impact factor: 11.583

6.  Bone marrow cell transfer into fetal circulation can ameliorate genetic skin diseases by providing fibroblasts to the skin and inducing immune tolerance.

Authors:  Takenao Chino; Katsuto Tamai; Takehiko Yamazaki; Satoru Otsuru; Yasushi Kikuchi; Keisuke Nimura; Masayuki Endo; Miki Nagai; Jouni Uitto; Yasuo Kitajima; Yasufumi Kaneda
Journal:  Am J Pathol       Date:  2008-08-07       Impact factor: 4.307

7.  Epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen.

Authors:  D T Woodley; R E Burgeson; G Lunstrum; L Bruckner-Tuderman; M J Reese; R A Briggaman
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

8.  Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa.

Authors:  Jennifer Remington; Xinyi Wang; Yingpin Hou; Hui Zhou; Julie Burnett; Trevor Muirhead; Jouni Uitto; Douglas R Keene; David T Woodley; Mei Chen
Journal:  Mol Ther       Date:  2008-11-18       Impact factor: 11.454

9.  The cartilage matrix protein subdomain of type VII collagen is pathogenic for epidermolysis bullosa acquisita.

Authors:  Mei Chen; Arvin Doostan; Pubali Bandyopadhyay; Jennifer Remington; Xinyi Wang; Yingping Hou; Ziu Liu; David T Woodley
Journal:  Am J Pathol       Date:  2007-06       Impact factor: 4.307

10.  Laminin 5 binds the NC-1 domain of type VII collagen.

Authors:  P Rousselle; D R Keene; F Ruggiero; M F Champliaud; M Rest; R E Burgeson
Journal:  J Cell Biol       Date:  1997-08-11       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.